InsiderTradesSIGMA

InsidersTradesSigma

Zealand Pharma A/S (ZEAL.CO) — directors' dealings · Healthcare &

← Companies ★ Sign in to follow

Zealand Pharma A/S: directors' dealings · Denmark · Finanstilsynet DK

DK:zealand-pharma-asDK0060257814DK·Finanstilsynet DKMcap 21.9Bn€Healthcare & Pharma

Explore the full management transaction log of Zealand Pharma A/S, a publicly traded company based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Zealand Pharma A/S has published 54 insider filings. Market capitalisation: €21.9bn. The latest transaction was reported on 22 April 2026 — Other. Among the most active insiders: Unknown. Every trade is openly available.

54

Insider Decl.

0

Thresholds

€286,102

4 ops.

Buy Volume

€6m

16 ops.

Sell Volume

Financial data

310.60 €

Analyst consensus

15 analysts

Buy

275.00 €Target 519.07 €(+67%)825.00 €

Valuation

PER (trailing)3.5x

PER (forward)38.4x

P/Book1.5x

Beta0.56

Balance sheet & cash

Market cap21.93 Bn€

Debt / Equity3%

Profitability & ownership

ROE56.2%

ROA34.7%

% insiders0.5%

% institutions49.2%

Last declaration on 22 April 2026

All Executives54 Thresholds Prospectus Other

Declarations54 total

Executives●Other18DK FSA

U

DKK 1m29,403 shares@ DKK 42.32280.0057% mcap95.0% of flow

ShareOutside a trading venue, XOFF

DK:1436237·20 Apr 2026

Executives●Grant11DK FSA

U

DKK 66,0921,500 shares@ DKK 44.06170.0003% mcap5.0% of flow

ShareOutside a trading venue, XOFF

DK:1435190·19 Apr 2026

Executives●Sale12DK FSA

U

€631 shares@ €62.50510.0000% mcap0.0% of flow

ShareNasdaq Copenhagen, XCSE

DK:1407692·17 Dec 2025

Executives●Other12DK FSA

U

€1m15,442 shares@ €65.28140.0046% mcap2.1% of flow

ShareOutside a trading venue, XOFF

DK:1404877·2 Dec 2025

Executives●Other16DK FSA

U

€6m106,680 shares@ €54.80570.027% mcap12.3% of flow

ShareOutside a trading venue, XOFF

DK:1366074·25 May 2025

Executives●Grant12DK FSA

U

€69,1771,217 shares@ €56.84220.0003% mcap0.1% of flow

ShareOutside a trading venue, XOFF

DK:1356822·19 Apr 2025

Executives●Other12DK FSA

U

01,090 shares0

ShareOutside a trading venue, XOFF

DK:1337157·9 Jan 2025

Executives●Other12DK FSA

U

Share

DK:1335333·25 Dec 2024

Executives●Sale12DK FSA

U

€113,9711,000 shares@ €113.97140.0005% mcap0.2% of flow

ShareNasdaq Copenhagen (OMX)

DK:1327123·8 Nov 2024

Executives●Sale16DK FSA

U

€4m35,000 shares@ €117.70730.019% mcap8.7% of flow

ShareNasdaq Copenhagen

DK:1314117·29 Aug 2024

Executives●Other25DK FSA

U

€28m12 shares@ €2,296,388.2840.13% mcap57.9% of flow

ShareOutside trading Venue

DK:1294926·12 May 2024

Executives●Other12DK FSA

U

€641,7888,008 shares@ €80.14340.0029% mcap1.3% of flow

ShareOutside the market

DK:1289217·19 Apr 2024

Executives●Other12DK FSA

U

€68,442854 shares@ €80.14340.0003% mcap0.1% of flow

ShareOutside the market

DK:1289173·19 Apr 2024

Executives●Sale12DK FSA

U

€190,9142,000 shares@ €95.45710.0009% mcap0.4% of flow

ShareNasdaq Copenhagen

DK:1284047·22 Mar 2024

Executives●Sale12DK FSA

U

€46,871500 shares@ €93.74220.0002% mcap0.1% of flow

ShareNasdaq Copenhagen

DK:1282221·15 Mar 2024

Executives●Sale12DK FSA

U

€99,1251,000 shares@ €99.1250.0005% mcap0.2% of flow

ShareNasdaq Copenhagen

DK:1280108·8 Mar 2024

Executives●Subscription12DK FSA

U

€156,2008,401 shares@ €18.59310.0007% mcap0.3% of flow

ShareOutside trading venue

DK:1279394·5 Mar 2024

Executives●Purchase12DK FSA

U

€84,7521,800 shares@ €47.08420.0004% mcap0.2% of flow

ShareNasdaq Copenhagen

DK:1263706·7 Dec 2023

Ideal exit: 2 Sept 2024 (T+270)

Executives●Other12DK FSA

U

€911,7962 shares@ €455,898.14750.0042% mcap1.9% of flow

ShareOutside trading Venue

DK:1262781·2 Dec 2023

Executives●Subscription12DK FSA

U

€45,1301,500 shares@ €30.08670.0002% mcap0.1% of flow

ShareOutside trading venue

DK:1247975·14 Sept 2023

Executives●Sale12DK FSA

U

€72,2392,035 shares@ €35.49820.0003% mcap0.2% of flow

ShareNasdaq Copenhagen

DK:1245819·31 Aug 2023

Executives●Sale12DK FSA

U

€108,1033,000 shares@ €36.03440.0005% mcap0.2% of flow

ShareNasdaq Copenhagen

DK:1244689·25 Aug 2023

Executives●Other15DK FSA

U

€3m71,120 shares@ €35.48960.012% mcap5.3% of flow

ShareOutside trading Venue

DK:1230283·25 May 2023

Executives●Other12DK FSA

U

€600,80417,372 shares@ €34.58460.0027% mcap1.3% of flow

ShareOutside trading venue

DK:1227780·12 May 2023

Executives●Sale12DK FSA

U

€1m45,000 shares@ €30.86330.0063% mcap2.9% of flow

ShareNasdaq Copenhagen

DK:1222419·25 Apr 2023

25 of 54 declarations

About Zealand Pharma A/S

Zealand Pharma A/S is a Danish biopharmaceutical company focused on developing treatments for metabolic and endocrine diseases. It emphasizes innovation in the field of therapeutic peptides.